Authors
Latest:
Oncology Drug Exkivity to be Voluntarily Withdrawn From US MarketExkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.
Latest:
Dry Eye Linked to Poor Sleep QualityAll components of sleep quality were reduced significantly in individuals with dry eye disease.
Latest:
Certain Factors May Increase Long COVID Risk in ChildrenChildren who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.
Latest:
Now #Trending: Picking and Choosing Items to Stock the Front-EndTapping into nostalgia is one way to guide front-end stock choices.
Latest:
Texting Can Boost Revenue and Patient CareEight ways texting can improve patient retention and boost revenue.
Latest:
Sickle Cell Disease Finally Getting Its DueTwo possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.
Latest:
The Effects of Psychedelics in Healthy ParticipantsIn a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.
Latest:
FDA Grants Priority Review to Liso-Cel in Relapsed/Refractory CLL/SLLThe FDA acceptance marks the first step in addressing the unmet need for a lasting treatment option for patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Latest:
Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass DartmouthThe Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.
Latest:
The Pharmacist’s Role Beyond COVID-19Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Thriving in a Digital World: Marketing Strategies for Independent PharmaciesCut through the online noise with these digital marketing tips for your independent pharmacy.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
Best Practices on Discussing Birth Control for AdolescentsThere are numerous methods of contraception available for adolescents.
Latest:
The Evolution of PharmacogenomicsPharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Latest:
Symptom Scoring Framework Helps Formalize Definition of Long COVIDFinalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.
Latest:
National Pharmacy Chain Opioid Settlements Poised to Affect Independent PharmaciesStipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Latest:
Understanding What Vaccines Could Mean for Long COVIDResearch suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
FDA, CDC Increase Availability of RSV Monoclonal Antibody for InfantsThe federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.
Latest:
Independent Pharmacy: A Year in Review & Insights from AbroadLearn how the challenges and opportunities of the last year have impacted independent pharmacy professionals around the world.
Latest:
Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.
Latest:
FDA: CBD Requires Separate Regulatory Pathway from Dietary Supplements, FoodThe agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.
Latest:
How Pharmacies Can Help Move Health Equity ForwardAs costs increase and the number of people in need further outpaces resources, it becomes increasingly urgent to find ways to further extend services to the people who need them.
Latest:
Early CT Screening Linked to Improved Lung Cancer SurvivalAlthough early computed tomography (CT) screening was associated with improved cure rate for patients with lung cancer, less than 6% of the population that is eligible receives it.
Latest:
FDA Approves Oral Treatment for Postpartum DepressionLast August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
Latest:
Pediatric Vaccines Strongly Recommended, Study ShowsNot every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.
Latest:
Breaking: Benzene Found in Acne Products From Major Brands, Prompts FDA Recall PetitionFollowing investigation by the independent testing laboratory, Valisure found acne products that contain up to 12 times the allowed of benzene.
Latest:
College Students and Misuse of SubstancesThe prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
